Detalles de la búsqueda
1.
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
JAMA
; 331(17): 1460-1470, 2024 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581198
2.
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
N Engl J Med
; 375(15): 1415-1424, 2016 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27626136
3.
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
JAMA
; 319(9): 883-895, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29509864
4.
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial.
BMJ Open
; 10(9): e036024, 2020 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907896
5.
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Health Technol Assess
; 24(37): 1-176, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32773013
6.
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Eur Urol
; 77(3): 320-330, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771797
7.
Training health professionals to recruit into challenging randomized controlled trials improved confidence: the development of the QuinteT randomized controlled trial recruitment training intervention.
J Clin Epidemiol
; 95: 34-44, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191445
8.
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial.
Eur Urol
; 71(3): 381-388, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27720537
9.
Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial.
BMJ Open
; 5(9): e008953, 2015 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26384727
10.
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].
Eur Urol
; 78(3): e139-e143, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32624282
11.
A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance.
J Clin Epidemiol
; 64(6): 628-36, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21239142
Resultados
1 -
11
de 11
1
Próxima >
>>